478 related articles for article (PubMed ID: 8988897)
1. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.
Estrada J; Boronat M; Mielgo M; Magallón R; Millan I; Díez S; Lucas T; Barceló B
N Engl J Med; 1997 Jan; 336(3):172-7. PubMed ID: 8988897
[TBL] [Abstract][Full Text] [Related]
2. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
3. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).
Wagenmakers MA; Netea-Maier RT; van Lindert EJ; Timmers HJ; Grotenhuis JA; Hermus AR
Clin Endocrinol (Oxf); 2009 Feb; 70(2):274-80. PubMed ID: 18616702
[TBL] [Abstract][Full Text] [Related]
4. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
Imaki T; Tsushima T; Hizuka N; Odagiri E; Murata Y; Suda T; Takano K
Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
[TBL] [Abstract][Full Text] [Related]
5. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J; Knappe UJ; Lüdecke DK
Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
[TBL] [Abstract][Full Text] [Related]
6. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
7. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
[TBL] [Abstract][Full Text] [Related]
8. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
Fomekong E; Maiter D; Grandin C; Raftopoulos C
Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of prognosis factors in the cure of Cushing's disease surgically treated via a +septotransphenoidal approach].
González JD; Gómez JM; Montanya E; Carrera MJ; Villabona C; Acebes JJ; Soler J
An Med Interna; 1997 Jul; 14(7):337-40. PubMed ID: 9410118
[TBL] [Abstract][Full Text] [Related]
10. Results of external pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.
Vicente A; Estrada J; de la Cuerda C; Astigarraga B; Marazuela M; Blanco C; Lucas T; Barceló B
Acta Endocrinol (Copenh); 1991 Nov; 125(5):470-4. PubMed ID: 1661997
[TBL] [Abstract][Full Text] [Related]
11. Biochemical predictors of outcome of pituitary surgery for Cushing's disease.
Alwani RA; de Herder WW; van Aken MO; van den Berge JH; Delwel EJ; Dallenga AH; De Jong FH; Lamberts SW; van der Lely AJ; Feelders RA
Neuroendocrinology; 2010; 91(2):169-78. PubMed ID: 19907141
[TBL] [Abstract][Full Text] [Related]
12. Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy.
Magiakou MA; Mastorakos G; Oldfield EH; Gomez MT; Doppman JL; Cutler GB; Nieman LK; Chrousos GP
N Engl J Med; 1994 Sep; 331(10):629-36. PubMed ID: 8052272
[TBL] [Abstract][Full Text] [Related]
13. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.
Bakiri F; Tatai S; Aouali R; Semrouni M; Derome P; Chitour F; Benmiloud M
J Endocrinol Invest; 1996 Oct; 19(9):572-80. PubMed ID: 8957739
[TBL] [Abstract][Full Text] [Related]
15. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
Chee GH; Mathias DB; James RA; Kendall-Taylor P
Clin Endocrinol (Oxf); 2001 May; 54(5):617-26. PubMed ID: 11380492
[TBL] [Abstract][Full Text] [Related]
16. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.
Storr HL; Plowman PN; Carroll PV; François I; Krassas GE; Afshar F; Besser GM; Grossman AB; Savage MO
J Clin Endocrinol Metab; 2003 Jan; 88(1):34-7. PubMed ID: 12519825
[TBL] [Abstract][Full Text] [Related]
17. Radiosurgery for Cushing's disease after failed transsphenoidal surgery.
Sheehan JM; Vance ML; Sheehan JP; Ellegala DB; Laws ER
J Neurosurg; 2000 Nov; 93(5):738-42. PubMed ID: 11059652
[TBL] [Abstract][Full Text] [Related]
18. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease.
Devoe DJ; Miller WL; Conte FA; Kaplan SL; Grumbach MM; Rosenthal SM; Wilson CB; Gitelman SE
J Clin Endocrinol Metab; 1997 Oct; 82(10):3196-202. PubMed ID: 9329338
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and long-term outcome in pituitary-dependent Cushing's disease.
Sonino N; Zielezny M; Fava GA; Fallo F; Boscaro M
J Clin Endocrinol Metab; 1996 Jul; 81(7):2647-52. PubMed ID: 8675592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
